These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33063311)

  • 41. Characteristics of Bilirubin According to the Results of the Direct Antiglobulin Test and Its Impact in Hemolytic Disease of the Newborn.
    Shin KH; Lee HJ; Song D; Lee SM; Kim IS; Kim H; Yang EJ; Park KH
    Lab Med; 2019 Apr; 50(2):138-144. PubMed ID: 30192966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Hospital Information System of the Brazilian National Unified Health System: a preliminary evaluation of performance in monitoring RhD hemolytic disease of the newborn].
    Lobato G; Reichenheim ME; Coeli CM
    Cad Saude Publica; 2008 Mar; 24(3):606-14. PubMed ID: 18327448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn.
    Zhang S; Li S; Meng X; Chen J; Tang Y; Li X
    Hematology; 2024 Dec; 29(1):2360339. PubMed ID: 38828919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of prenatal joint detection of ABO antibody titers and irregular antibodies in pregnant women with type O blood.
    Zhu WY; Li HX; Liang Y
    Clin Exp Obstet Gynecol; 2014; 41(1):28-31. PubMed ID: 24707678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early diagnosis of ABO haemolytic disease of the newborn.
    Procianoy RS; Giacomini CB; Farina DM; Mollin GA; Winckler MI; Silveira MB; Campos L; Marques-Pereira JP
    Eur J Pediatr; 1987 Jul; 146(4):390-3. PubMed ID: 3653135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
    Onesimo R; Rizzo D; Ruggiero A; Valentini P
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenetic studies of maternal-fetal relationships: a review: why newborn rhesus monkeys don't get hemolytic disease.
    Treichel RS
    Genetica; 1987 Aug; 73(1-2):69-79. PubMed ID: 3333354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.
    Lucas GF; Hadley AG; Nance SJ; Garratty G
    Transfusion; 1993 Jun; 33(6):484-7. PubMed ID: 8516790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in the management of Rh hemolytic disease of the newborn (HDN).
    Gupte SC
    Indian J Med Sci; 1995 Mar; 49(3):66-72. PubMed ID: 7558217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.